Turing Pharmaceuticals, which drew ire after raising the price of Daraprim more than 50-fold, said it will discount the drug as much as 50% to hospitals and take other steps to help patients afford the cost.
WSJ.com: Health, Wall Street Journal: Business: Health
Tue, 11/24/2015 - 4:54pm
Turing Pharmaceuticals, which drew ire after raising the price of Daraprim more than 50-fold, said it will discount the drug as much as 50% to hospitals and take other steps to help patients afford the cost.